VEON to report 2Q26 results on July 31, 2026
VEON Ltd. announced it will report its 2Q26 and first-half 2026 financial results on July 31, 2026. The company will host an earnings call in New York, offering in-person, webcast, and YouTube livestream options. Shareholders can engage with management through a Q&A platform starting July 23, 2026.

*this image is generated using AI for illustrative purposes only.
VEON Ltd. will release its financial and operating results for the second quarter and first-half ended June 30, 2026, on July 31, 2026. The digital operator confirmed the results will be published at 8:00 GST / 0:00 ET. Senior management will host a results presentation and earnings call at 17:00 GST / 9:00 ET the same day, marking a shift to hold the event in New York.
Earnings call details
Investors and analysts are invited to join management in person at The Lotte New York Palace, located at 455 Madison Avenue, New York, NY 10022. Advance registration is mandatory for physical attendance due to limited space. Participants must contact VEON Investor Relations at ir@veon.com to confirm participation.
Access options
The event will be accessible through multiple channels. Registration for the webcast and dial-in details is available online. Additionally, the conference call will be livestreamed on YouTube, allowing real-time access without registration.
| Event | Time (GST) | Time (ET) | Location/Link |
|---|---|---|---|
| Results release | 8:00 | 0:00 | Online |
| Earnings call | 17:00 | 9:00 | The Lotte New York Palace / Webcast / YouTube |
Shareholder engagement
VEON is partnering with Say Technologies to facilitate engagement. Retail and institutional shareholders can submit and upvote questions for the management team via a dedicated Q&A platform. The platform opens on July 23, 2026, at 8:00 ET and remains open until 24 hours before the conference call. Questions can also be emailed directly to ir@veon.com .
What strategic factors influenced VEON's decision to shift the earnings call to New York?
How might the move to New York impact VEON's engagement with North American investors?
Could this shift signal a broader change in VEON's operational or strategic focus?
































